Variant report
Variant | nsv1012430 |
---|---|
Chromosome Location | chr3:24924319-24942605 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:57861594..57864060-chr3:24935061..24936561,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000267637 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571047918 | chr3:24924322-24924323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546848705 | chr3:24924343-24924344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138157683 | chr3:24924382-24924383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535639634 | chr3:24924397-24924398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142535802 | chr3:24924414-24924415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2362775 | chr3:24924421-24924422 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs539500536 | chr3:24924427-24924428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557486412 | chr3:24924443-24924444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190648316 | chr3:24924473-24924474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535035535 | chr3:24924478-24924479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571778962 | chr3:24924494-24924495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6550923 | chr3:24924495-24924496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554262553 | chr3:24924510-24924511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375668262 | chr3:24924533-24924534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542020725 | chr3:24924543-24924544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545947722 | chr3:24924549-24924550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557091154 | chr3:24924678-24924679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370354034 | chr3:24924705-24924706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575348538 | chr3:24924753-24924754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546248491 | chr3:24924794-24924795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368557682 | chr3:24924848-24924849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs3221508 | chr3:24924850-24924851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529541190 | chr3:24924871-24924872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs397837329 | chr3:24924880-24924881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs72554268 | chr3:24924885-24924886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs3057220 | chr3:24924886-24924887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574172251 | chr3:24924903-24924904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144798233 | chr3:24924916-24924917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs57267142 | chr3:24924950-24924951 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs540202866 | chr3:24924953-24924954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11715275 | chr3:24924970-24924971 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs529156803 | chr3:24924985-24924986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550805362 | chr3:24924991-24924992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138847320 | chr3:24925017-24925018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182979229 | chr3:24925018-24925019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551435742 | chr3:24925040-24925041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115463265 | chr3:24925070-24925071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533779794 | chr3:24925119-24925120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149379184 | chr3:24925149-24925150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568422220 | chr3:24925165-24925166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144651876 | chr3:24925183-24925184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557676051 | chr3:24925189-24925190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557152555 | chr3:24925213-24925214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533600326 | chr3:24925230-24925231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546013093 | chr3:24925233-24925234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571233260 | chr3:24925256-24925257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188421850 | chr3:24925337-24925338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547586095 | chr3:24925341-24925342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148506537 | chr3:24925347-24925348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562025137 | chr3:24925397-24925398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:24924200-24924600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr3:24924600-24928000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr3:24927800-24928400 | Enhancers | Fetal Kidney | kidney |
4 | chr3:24928000-24928200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr3:24928000-24928200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr3:24928200-24929400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr3:24929400-24929600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr3:24930400-24930600 | Enhancers | Fetal Lung | lung |
9 | chr3:24930600-24931600 | Weak transcription | Fetal Lung | lung |
10 | chr3:24931600-24931800 | Enhancers | Fetal Lung | lung |
11 | chr3:24934000-24934200 | Enhancers | Fetal Lung | lung |
12 | chr3:24940400-24942600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |